Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 8/20 | 0.84 |
| ▸ | DPP4 | P27487 | 2/20 | 0.82 |
| ▸ | MAOA | P21397 | 1/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.55 |
| ▸ | SNCA | P37840 | 3/20 | 0.55 |
| ▸ | EGFR | P00533 | 2/20 | 0.55 |
| ▸ | KDR | P35968 | 2/20 | 0.55 |
| ▸ | EP300 | Q09472 | 2/20 | 0.55 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.55 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | BCR | P11274 | 1/20 | 0.41 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7527028 | 1.00 | CD38 (0.84) | CD38DPP4MAOAALDH1A1TSHR | |
| Malvidin SCHEMBL21739 | 0.91 | CD38 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| SCHEMBL129253 | 0.91 | CD38 (0.70) | CD38DPP4MAOAALDH1A1TSHR | |
| Malvidin SCHEMBL29406694 | 0.91 | CD38 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Malvidin SCHEMBL29640416 | 0.90 | DPP4 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Malvidin SCHEMBL308690 | 0.90 | DPP4 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Malvidin SCHEMBL30683334 | 0.90 | DPP4 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Petunidin SCHEMBL29372982 | 0.87 | CD38 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Petunidin SCHEMBL21650 | 0.87 | CD38 (1.00) | CD38DPP4MAOAALDH1A1TSHR | |
| Petunidin SCHEMBL30884156 | 0.87 | CD38 (1.00) | CD38DPP4MAOAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-11-09 | — | — | US | claimed |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-10-26 | — | — | US | claimed |
| EP-3573748-B1 | COLOURED ORGANIC/INORGANIC HYBRID MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-19 | — | — | EP | claimed |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| EP-4674283-A1 | A COMPOSITION FOR IMPARTING A CURED MEAT APPEARANCE AND/OR FLAVOUR | Kerry Group Services International Limited (IE) | 2026-01-07 | — | — | EP | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| EP-4601666-A2 | COMPOSITION COMPRISING AQUEOUS PLANT EXTRACT AND/OR ESSENTIAL OIL AND CAFFEINE AND APPLICATION THEREOF FOR IMPROVING COGNITIVE AND MOOD FUNCTIONS | The Coca-Cola Company (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-20250222060-A1 | POLYPHENOL COMPOSITION AND METHOD OF ITS USE AND MANUFACTURE IN REDUCING BODY WEIGHT | Vidya Herbs, Inc. (US) | 2025-07-10 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| US-12274730-B2 | Flavonoid compositions and methods of use | BERKLEY, LLC (US) | 2025-04-15 | — | — | US | disclosed |
| EP-4142728-A1 | 6'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL INFECTIONS | Immunologik GmbH (DE) | 2023-03-08 | — | — | EP | disclosed |
| US-11590475-B2 | Photoluminescent hybrid organic/inorganic materials and method for preparing same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-02-28 | — | — | US | disclosed |
| WO-2022272114-A1 | ORALLY CONSUMABLE COMPOSITION WITH PLANT EXTRACT | THE COCA-COLA COMPANY (US) | 2022-12-29 | — | — | WO | disclosed |
| CN-115515587-A | 6' -methoxycinchonin-9-ols for the treatment of coronavirus infections | 免疫学有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-11376570-B1 | Method of forming copper oxide-on-copper nanomaterial catalyst mesh | KING ABDULAZIZ UNIVERSITY (SA) | 2022-07-05 | — | — | US | disclosed |
| EP-3986420-A1 | NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES | Mitopower LLC (US) | 2022-04-27 | — | — | EP | disclosed |
| US-11311492-B1 | Carbon nanomedicine with natural ligands | KING ABDULAZIZ UNIVERSITY (SA) | 2022-04-26 | — | — | US | disclosed |
| WO-2022025598-A1 | COMPOSITION FOR INDUCING DIFFERENTIATION FROM PLURIPOTENT STEM CELLS INTO MESENCHYMAL STEM CELLS COMPRISING SMAD1/5/8 ACTIVATOR AND USE THEREOF | 삼성전자 주식회사 | 2022-02-03 | — | — | WO | disclosed |
| US-11234940-B1 | Method for making a noble metal nanomedicine | KING ABDULAZIZ UNIVERSITY (SA) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | CD38 2308/4885DPP4 4789/4885MAOA 831/4885 |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | CD38 2308/4885DPP4 4789/4885MAOA 831/4885 |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | CD38 1656/4885DPP4 176/4885MAOA 3217/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | CD38 2712/4885DPP4 478/4885MAOA 3606/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | CD38 1949/4885DPP4 150/4885MAOA 3285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.